GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on May 07, 2013, to consider, approval of unaudited financial results for the quarter ended March 31, 2013 (Q1).
The above information is a part of company’s filings submitted to BSE.